Carolyn Childers and Lindsay Kaplan identified a lack of resources and community for the 5 million women in America who identify as senior leaders. The duo launched Chief to help women build lines of succession into these leadership positions. AlleyWatch caught up with Carolyn to learn more about the flourishing business (8000+ waitlist) and the company’s transition to offer virtual services in the wake of the pandemic.
While working as a commercial real estate developer, William Sankey was convinced there was a better way to manage complex, multi-million-dollar projects that didn’t involve paper-based workflows, data entry, filing cabinets, and “gut feelings”. He cofounded Northspyre, a cloud intelligence platform that automates workflow and reveals data insights for the CRE industry. AlleyWatch caught up with Sankey to learn more about the company’s product, traction, and recent funding round.
This bi-weekly column covers the latest news from venture capital firms in NYC for the second half of May 2020 featuring must-know news including news for Founder Collective, Apeira Capital, and much more.
The latest venture capital, seed, pre-seed, and angel deals for NYC startups for 6/1/2020 featuring funding details for Propagate Ventures, NEOU, and much more.
The notable startup fundings for the week ending 5/30/20 featuring funding details for Gatsby, SmartRent, Funbox, and much much more.
The promise of big data and machine learning has significant ramifications for treatments in the healthcare industry. However, due to privacy concerns, innovation is often stifled. Thomas Clozel, MD, an assistant professor of oncology, saw this roadblock firsthand and cofounded Owkin – a collaborative platform that allows medical researchers to gain insights from decentralized data without breaching any privacy protocols. Clozel offers some insight into how Owkin is changing the medical research landscape powered by machine learning and algorithms.
The latest venture capital, seed, pre-seed, and angel deals for NYC startups for 5/29/2020 featuring funding details for Accern and much more.
Many venture funds believe they can predict what is going to happen next and where. They invest based on that certainty, focusing in specific regions, or on specific types of tech, or, commonly, both. At our funds, we know it’s impossible to predict exactly what is going to happen next or where. Instead, we study […]